These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31476323)

  • 1. Advances in asthma, asthma-COPD overlap, and related biologics in 2018.
    Bacharier LB; Mori A; Kita H
    J Allergy Clin Immunol; 2019 Oct; 144(4):906-919. PubMed ID: 31476323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking the red out of eosinophilic inflammation in COPD.
    Bush RK
    J Allergy Clin Immunol; 2020 Aug; 146(2):278-279. PubMed ID: 32502512
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO): a scoping review protocol.
    Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
    BMJ Open; 2017 Dec; 7(12):e018954. PubMed ID: 29273668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the pathophysiology of the asthma-chronic obstructive pulmonary disease overlap syndrome.
    Gelb AF; Nadel JA
    J Allergy Clin Immunol; 2015 Sep; 136(3):553-5. PubMed ID: 26343939
    [No Abstract]   [Full Text] [Related]  

  • 5. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome.
    Nakawah MO; Hawkins C; Barbandi F
    J Am Board Fam Med; 2013; 26(4):470-7. PubMed ID: 23833163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation.
    Nixon J; Newbold P; Mustelin T; Anderson GP; Kolbeck R
    Pharmacol Ther; 2017 Jan; 169():57-77. PubMed ID: 27773786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of airway epithelial cell culture to unravel the pathogenesis and study treatment in obstructive airway diseases.
    Mertens TCJ; Karmouty-Quintana H; Taube C; Hiemstra PS
    Pulm Pharmacol Ther; 2017 Aug; 45():101-113. PubMed ID: 28502841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?
    Slats A; Taube C
    Ther Adv Respir Dis; 2016 Feb; 10(1):57-71. PubMed ID: 26596632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.
    Kostikas K; Brindicci C; Patalano F
    Curr Drug Targets; 2018; 19(16):1882-1896. PubMed ID: 29437007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.
    Barrecheguren M; Esquinas C; Miravitlles M
    Curr Opin Pulm Med; 2015 Jan; 21(1):74-9. PubMed ID: 25405671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology of asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    Nat Rev Immunol; 2008 Mar; 8(3):183-92. PubMed ID: 18274560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Same role and same treatment for airway eosinophilia in asthma and COPD?
    Maestrelli P
    Eur Respir J; 2007 May; 29(5):831-3. PubMed ID: 17470618
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of biologics to treat acute exacerbations and manage disease in asthma, COPD and IPF.
    Murray LA; Grainge C; Wark PA; Knight DA
    Pharmacol Ther; 2017 Jan; 169():1-12. PubMed ID: 27889330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma and COPD overlap pathophysiology of ACO.
    Hikichi M; Hashimoto S; Gon Y
    Allergol Int; 2018 Apr; 67(2):179-186. PubMed ID: 29550368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to the Canadian Scientific Advisory Committee on Respiratory and Allergy Therapies: in vivo evaluation for clinical testing in COPD and asthma therapy using generics.
    Mayers I
    J Aerosol Med Pulm Drug Deliv; 2012 Aug; 25(4):204-8. PubMed ID: 22007673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the Asthma-COPD Overlap Syndrome (ACOS): a Review of the Evidence.
    Hines KL; Peebles RS
    Curr Allergy Asthma Rep; 2017 Mar; 17(3):15. PubMed ID: 28283854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting 5-lipoxygenase-activating protein in asthma and chronic obstructive pulmonary disease.
    Antoniu SA
    Expert Opin Ther Targets; 2014 Nov; 18(11):1285-92. PubMed ID: 25213852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies for asthma and chronic obstructive pulmonary disease.
    Antoniu SA
    Expert Opin Biol Ther; 2013 Feb; 13(2):257-68. PubMed ID: 23282002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma versus chronic obstructive pulmonary disease, the Dutch versus British hypothesis, and role of interleukin-5.
    Chambliss JM; Sur S; Tripple JW
    Curr Opin Allergy Clin Immunol; 2018 Feb; 18(1):26-31. PubMed ID: 29257776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap.
    Lau EMT; Roche NA; Reddel HK
    Expert Rev Clin Immunol; 2017 May; 13(5):449-455. PubMed ID: 27977310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.